The central role of macrophages in trypanosomiasis-associated anemia: Rationale for therapeutical approaches

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 10, Issue 1, 2010, Pages 71-82

  Stijlemans, Benoît ^a,b   Vankrunkelsven, Ann ^a,b   Caljon, Guy ^a,b,c   Bockstal, Viki ^a,b   Guilliams, Martin ^a,b   Bosschaerts, Tom ^a,b   Beschin, Alain ^a,b   Raes, Geert ^a,b   Magez, Stefan ^a,b   De Baetselier, Patrick ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Anemia of inflammation; Erythropoiesis; GPI; Iron homeostasis; Macrophage activation; Trypanosomiasis

Indexed keywords

ADENOVIRUS VECTOR; GLYCOLIPID; GLYCOSYLPHOSPHATIDYLINOSITOL; INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 10;

ANEMIA; CELL FUNCTION; CHRONIC DISEASE; CYTOKINE PRODUCTION; HOMEOSTASIS; HUMAN; INFLAMMATION; IRON METABOLISM; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; PATHOLOGY; REVIEW; T LYMPHOCYTE; TRYPANOSOMIASIS; VIRAL GENE DELIVERY SYSTEM;

EID: 77950817192     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153010790827966     Document Type: Review

References (112)

1. Cecchi, G.; Paone, M.; Franco, J.R.; Fevre, E.M.; Diarra, A.; Ruiz, J.A.; Mattioli, R.C. and Simarro, P.P. (2009) Towards the Atlas of human African trypanosomiasis. Int. J. Health Geogr., 8, 15.
2. Stanghellini, A. and Josenando, T. (2001) The situation of sleepingsickness in Angola: a calamity. Trop. Med. Int. Health, 6, 330-334.
3. Van Nieuwenhove, S.; Betu-Ku-Mesu, V.K.; Diabakana, P.M.;Declercq, J. and Bilenge, C.M. (2001) Sleeping sickness resurgence in the DRC: the past decade. Trop. Med. Int. Health, 6, 335-341.
4. Stich, A.; Barrett, M.P. and Krishna, S. (2003) Waking up to sleepingsickness. Trends Parasitol., 19, 195-197.
5. Steverding, D. (2008) The history of African trypanosomiasis. Parasit. Vectors, 1, 3.
6. Connor, R.J. (1994) The impact of nagana. Onderstepoort. J. Vet.Res., 61, 379-383.
7. Anene, B.M.; Onah, D.N. and Nawa, Y. (2001) Drug resistance in pathogenic African trypanosomes: what hopes for the future? Vet.Parasitol., 96, 83-100.
8. Maser, P.; Luscher, A. and Kaminsky, R. (2003) Drug transportand drug resistance in African trypanosomes. Drug Resist. Updat., 6, 281-290.
9. Geerts, S.; Holmes, P.H.; Eisler, M.C. and Diall, O. (2001) African bovine trypanosomiasis: the problem of drug resistance. Trends Parasitol., 17, 25-28.
10. Naessens, J. (2006) Bovine trypanotolerance: a natural ability to prevent severe anaemia and haemophagocytic syndrome? Int. J. Parasitol., 36, 521-528.
11. Holmes, P.H.; Katunguka-Rwakishaya, E.; Bennison, J.J.;Wassink, G.J. and Parkins, J.J. (2000) Impact of nutrition on the pathophysiology of bovine trypanosomiasis. Parasitology, 120 S73-S85.
12. Faye, D.; Fall, A.; Leak, S.; Losson, B. and Geerts, S. (2005) Influenceof an experimental Trypanosoma congolense infection and plane of nutrition on milk production and some biochemical parameters in West African Dwarf goats. Acta Trop., 93, 247-257.
13. Katunguka-Rwakishaya, E.; Murray, M. and Holmes, P.H. (1999)The influence of energy intake on some blood biochemical parameters in Scottish Blackface sheep infected with Trypanosoma congolense. Vet. Parasitol., 84, 1-11.
14. Katunguka-Rwakishaya, E.; Parkins, J.J.; Fishwick, G.; Murray, M.and Holmes, P.H. (1995) The influence of energy intake on the pathophysiology of Trypanosoma congolense infection in Scottish blackface sheep. Vet. Parasitol., 59, 207-218.
15. Van den Bossche, P.R.G.J. (2001) The relationship between the parasitological prevelance of trypanosomal infections in cattle and herd average packed cell volume. Acta Tropica., 78, 163-170.
16. Naessens, J.; Leak, S.G.; Kennedy, D.J.; Kemp, S.J. and Teale, A.J. (2003) Responses of bovine chimaeras combining trypanosomosisresistant and susceptible genotypes to experimental infection with Trypanosoma congolense. Vet. Parasitol., 111, 125-142.
17. Magez, S.; Truyens, C.; Merimi, M.; Radwanska, M.; Stijlemans,B.; Brouckaert, P.; Brombacher, F.; Pays, E. and De Baetselier, P. (2004) P75 tumor necrosis factor-receptor shedding occurs as a protective host response during African trypanosomiasis. J. Infect. Dis., 189, 527-539.
18. Mansfield, J.M. and Paulnock, D.M. (2005) Regulation of innateand acquired immunity in African trypanosomiasis. Parasite Immunol., 27, 361-371.
19. Magez, S.; Schwegmann, A.; Atkinson, R.; Claes, F.; Drennan, M.;De Baetselier, P. and Brombacher, F. (2008) The role of B-cells and IgM antibodies in parasitemia, anemia, and VSG switching in Trypanosoma brucei-infected mice. PLoS Pathog., 4, e1000122.
20. Vanhamme, L.; Pays, E.; McCulloch, R. and Barry, J.D. (2001) An update on antigenic variation in African trypanosomes. Trends Parasitol., 17, 338-343.
21. Darji, A.; Lucas, R.; Magez, S.; Torreele, E.; Palacios, J.; Sileghem, M.; Bajyana, S.E.; Hamers, R. and De Baetselier, P. (1992) Mechanisms underlying trypanosome-elicited immunosuppression. Ann. Soc. Belg. Med. Trop., 72, 27-38.
22. Donelson, J.E.; Hill, K.L. and El-Sayed, N.M. (1998) Multiple mechanisms of immune evasion by African trypanosomes. Mol.Biochem. Parasitol., 91, 51-66.
23. Shi, M.; Pan, W. and Tabel, H. (2003) Experimental African trypanosomiasis: IFN-gamma mediates early mortality. Eur. J. Immunol., 33, 108-118.
24. Bosschaerts, T.; Guilliams, M.; Stijlemans, B.; De Baetselier, P. and Beschin, A. (2009) Understanding the role of monocytic cellsin liver inflammation using parasite infection as a model. Immunobiology, 214, 737-747.
25. Stijlemans, B.; Vankrunkelsven, A.; Brys, L.; Magez, S. and DeBaetselier, P. (2008) Role of iron homeostasis in trypanosomiasisassociated anemia. Immunobiology, 213, 823-835.
26. De Baetselier, P.D.; Namangala, B.; Noel, W.; Brys, L.; Pays, E. and Beschin, A. (2001) Alternative versus classical macrophage activation during experimental African trypanosomosis. Int. J. Parasitol., 31, 575-587.
27. Harris, T.H.; Cooney, N.M.; Mansfield, J.M. and Paulnock, D.M. (2006) Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome NA. Infect. Immun., 74, 4530-4537.
28. Namangala, B.; De Baetselier, P.; Noel, W.; Brys, L. and Beschin, A. (2001) Alternative versus classical macrophage activation during experimental African trypanosomosis. J. Leukoc. Biol., 69, 387-396
29. Magez, S.; Radwanska, M.; Beschin, A.; Sekikawa, K. and De Baetselier, P. (1999) Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect. Immun., 67, 3128-3132.
30. Magez, S.; Radwanska, M.; Drennan, M.; Fick, L.; Baral, T.N.;Brombacher, F. and De Baetselier, P. (2006) Interferon-gamma and nitric oxide in combination with antibodies are key protective host immune factors during trypanosoma congolense Tc13 Infections. J. Infect. Dis., 193, 155-1583.
31. Magez, S.; Radwanska, M.; Drennan, M.; Fick, L.; Baral, T.N.;Allie, N.; Jacobs, M.; Nedospasov, S.; Brombacher, F.; Ryffel, B. and De Baetselier, P. (2007) Tumor necrosis factor (TNF) receptor-1 (TNFp55) signal transduction and macrophage-derived soluble TNF are crucial for nitric oxide-mediated Trypanosoma congolense parasite killing. J. Infect. Dis., 196, 954-962.
32. Vincendeau, P.; Daulouede, S.; Veyret, B.; Darde, M.L.; Bouteille, B. and Lemesre, J.L. (1992) Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei. Exp. Parasitol., 75, 353-360.
33. Shi, M.; Wei, G.; Pan, W. and Tabel, H. (2004) Trypanosoma congolense infections: antibody-mediated phagocytosis by Kupffer cells. J. Leukoc. Biol., 76, 399-405.
34. Bakhiet, M.; Olsson, T.; Edlund, C.; Hojeberg, B.; Holmberg, K.; Lorentzen, J. and Kristensson, K. (1993) A Trypanosoma brucei brucei-derived factor that triggers CD8+ lymphocytes to interferongamma secretion: purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand. J. Immunol., 37, 165-178.
35. Magez, S.; Stijlemans, B.; Baral, T. and De Baetselier, P. (2002) VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect., 4, 999-1006.
36. Magez, S.; Stijlemans, B.; Radwanska, M.; Pays, E.; Ferguson, M.A. and De Baetselier, P. (1998) The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J. Immunol., 160, 1949-1956.
37. Schofield, L.; Novakovic, S.; Gerold, P.; Schwarz, R.T.; McConville, M.J. and Tachado, S.D. (1996) Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J. Immunol., 156, 1886-1896.
38. Shoda, L.K.; Kegerreis, K.A.; Suarez, C.E.; Roditi, I.; Corral, R.S.; Bertot, G.M.; Norimine, J. and Brown, W.C. (2001) DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide. Infect. Immun., 69, 2162-2171.
39. Tachado, S.D.; Gerold, P.; Schwarz, R.; Novakovic, S.; McConville, M. and Schofield, L. (1997) Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc. Natl. Acad. Sci. USA, 94, 4022-4027.
40. Gomez-Rodriguez, J.S.B.; De Muylder, G.; Korf, JE.; Brys, L.;Berberof, M.; Darji, A.; Pays, E.; De Baetselier, P. and Beschin A. (2009) Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis. J. Infect. Dis., 200, 1849-1860.
41. Lucas, R.; Magez, S.; Songa, B.; Darji, A.; Hamers, R. and de Baetselier, P. (1993) A role for TNF during African trypanosomiasis: involvement in parasite control, immunosuppression and pathology. es. Immunol., 144, 370-376.
42. Sileghem, M.; Flynn, J.N.; Logan-Henfrey, L. and Ellis, J. (1994) Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity ofanaemia assoc iated with the disease. Parasite Immunol., 16, 51-54.
43. Darji, A.; Beschin, A.; Sileghem, M.;Heremans, H.; Brys, L. and De Baetselier, P. (1996) In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect. Immun., 64, 1937-1943.
44. Ferguson, M.A.; Brimacombe, J.S.; Cottaz, S.; Field, R.A.; Guther, L.S.; Homans, S.W.; McConville, M.J.; Mehlert, A.; Milne, K.G.; Ralton, J.E. (1994) Glycosyl-phosphatidylinositol molecules of the parasite and the host. Parasitology, 108, S45-S54.
45. Paulnock, D.M. and Coller, S.P. (2001) Analysis of macrophage activation in African trypanosomiasis. J. Leukoc. Biol., 69, 685-690.
46. Rolin, S.; Hanocq-Quertier, J.; Paturiaux-Hanocq, F.; Nolan, D.; Salmon, D.; Webb, H.; Carrington, M.; Voorheis, P. and Pays, E. (1996) Simultaneous but independent activation of adenylate cyclase and glycosylphosphatidylinositol- phospholipase C understress conditions in Trypanosoma brucei. J. Biol. Chem., 271, 10844-10852
47. Rolin, S.; Hancocq-Quertier, J.; Paturiaux-Hanocq, F.; Nolan, D.P. and Pays, E. (1998) Mild acid stress as a differentiation trigger in Trypanosoma brucei. Mol. Biochem. Parasitol., 93, 251-262.
48. Hanrahan, O.; Webb, H.; O'Byrne, R.; Brabazon, E.; Treumann, A.; Sunter, J.D.; Carrington, M. and Voorheis, H.P. (2009) The glycosylphosphatidylinositol- PLC in Trypanosoma brucei forms a linear array on the exterior of the flagellar membrane before and after activation. PLoS Pathog., 5, e1000468.
49. Fox, J.A.; Duszenko, M.; Ferguson, M.A.; Low, M.G. and Cross,G.A. (1986) Purification and characterization of a novel glycanphosphatidylinositol-specific phospholipase C from Trypanosoma brucei. J. Biol. Chem., 261, 15767-15771.
50. Carrington, M.; Carnall, N.; Crow, M.S.; Gaud, A.; Redpath, M.B.; Wasunna, C.L. and Webb, H. (1998) The properties and function of the glycosylphosphatidylinositol-phospholipase C in Trypanosoma brucei. Mol. Biochem. Parasitol., 91, 153-164.
51. Sileghem, M.; Saya, R.; Grab, D.J. and Naessens, J. (2001) Anaccessory role for the diacylglycerol moiety of variable surface glycoprotein of African trypanosomes in the stimulation of bovine monocytes. Vet. Immunol. Immunopathol., 78, 325-339.
52. Olsson, T.; Bakhiet, M.; Hojeberg, B.; Ljungdahl, A.; Edlund, C.; Andersson, G.; Ekre, H.P.; Fung-Leung, W.P.; Mak, T.; Wigzell, H. (1993) CD8 is critically involved in lymphocyte activation by a T. brucei brucei-released molecule. Cell, 72, 715-727.
53. Ngure, R.M.; Eckersall, P.D.; Mungatana, N.K.; Mburu, J.N.; Jennings, F.W.; Burke, J. and Murray, M. (2009) Lipopolysaccharide binding protein in the acute phase response of experimental murine Trypanosoma brucei brucei infection. Res. Vet. Sci., 86,394-398.
54. Ngure, R.M.; Eckersall, P.; Burke, J.; Karori, S.M.; Mwangi, W.W.; Wachira, F.N.; Maathai, R. and Murray, M. (2009) Endotoxin-like effects in acute phase response to Trypanosoma brucei brucei infection are not due to gastrointestinal leakage. Parasitol.Int., 58, 325-329.
55. Nyakundi, J.N.; Crawley, B.; Smith, R.A. and Pentreath, V.W.(2002) The relationships between intestinal damage and circulating endotoxins in experimental Trypanosoma brucei brucei infections. Parasitology, 124, 589-595.
56. Nyakundi, J.N.; Crawley, B. and Pentreath, V.W. (2002) The relationships between endotoxins, nitric oxide and inflammatory cytokines in blood and intestinal tissues in experimental Trypanosoma brucei brucei infections. Parasitology, 124, 597-604.
57. Schofield, L. and Tachado, S.D. (1996) Regulation of host cell function by glycosylphosphatidylinositols of the parasitic protozoa. Immunol. Cell Biol., 74, 555-563.
58. Tachado, S.D. and Schofield, L. (1994) Glycosylphosphatidylinositol toxin of Trypanosoma brucei regulates IL-1 alpha and TNFalpha expression in macrophages by protein tyrosine kinase mediated signal transduction. Biochem. Biophys. Res. Commun., 205,984-991.
59. Namangala, B.; de Baetselier, P.; Brijs, L.; Stijlemans, B.; Noel, W.; Pays, E.; Carrington, M. and Beschin, A. (2000) Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines. J. Infect.Dis., 181, 1110-1120.
60. Leppert, B.J.; Mansfield, J.M. and Paulnock, D.M. (2007) The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. J. Immunol., 179, 548-556.
61. Drennan, M.B.; Stijlemans, B.; Van den Abbeele, J.; Quesniaux,V.J.; Barkhuizen, M.; Brombacher, F.; De Baetselier, P.; Ryffel, B. and Magez, S. (2005) The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J. Immunol., 175, 2501-2509.
62. Almeida, I.C.; Camargo, M.M.; Procopio, D.O.; Silva, L.S.;Mehlert, A.; Travassos, L.R.; Gazzinelli, R.T. and Ferguson, M.A. (2000) Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents. EMBO. J., 19, 1476-1485.
63. Mensa-Wilmot, K.; Garg, N.; McGwire, B.S.; Lu, H.G.; Zhong, L.; Armah, D.A.; LeBowitz, J.H. and Chang, K.P. (1999) Roles of free GPIs in amastigotes of Leishmania. Mol. Biochem. Parasitol., 99, 103-116.
64. Tachado, S.D.; Gerold, P.; McConville, M.J.; Baldwin, T.; Quilici, D.; Schwarz, R.T. and Schofield, L. (1996) Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosinekinase-dependent and protein kinase C-dependent signaling pathway. J. Immunol., 156, 1897-1907.
65. Perraut, R.; Diatta, B.; Marrama, L.; Garraud, O.; Jambou, R.; Longacre, S.; Krishnegowda, G.; Dieye, A. and Gowda, D.C. (2005) Differential antibody responses to Plasmodium falciparum glycosylphosphatidylinositol anchors in patients with cerebral and mild malaria. Microbes Infect., 7, 682-687.
66. Naik, R.S.; Branch, O.H.; Woods, A.S.; Vijaykumar, M.; Perkins,D.J.; Nahlen, B.L.; Lal, A.A.; Cotter, R.J.; Costello, C.E.; Ockenhouse, C.F.; Davidson, E.A. and Gowda, D.C. (2000) Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis. J. Exp. Med.,192, 1563-1576.
67. Schofield, L.; Hewitt, M.C.; Evans, K.; Siomos, M.A. and Seeberger, P.H. (2002) Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature, 418, 785-789.
68. Stijlemans, B.; Baral, T.N.; Guilliams, M.; Brys, L.; Korf, J.;Drennan, M.; Van Den Abbeele, J.; De Baetselier, P. and Magez, S. (2007) A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis- associated immunopathology. J. Immunol., 179,4003-4014.
69. Authie, E.; Boulange, A.; Muteti, D.; Lalmanach, G.; Gauthier, F. and Musoke, A.J. (2001) Immunisation of cattle with cysteine proteinases of Trypanosoma congolense: targetting the disease rather than the parasite. Int. J. Parasitol., 31, 1429-1433.
70. Mantovani, A.; Sica, A.; Sozzani, S.; Allavena, P.; Vecchi, A. and Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol., 25, 677-686.
71. Mosser, D.M. (2003) The many faces of macrophage activation. J. Leukoc. Biol., 73, 209-212.
72. Coller, S.P.; Mansfield, J.M. and Paulnock, D.M. (2003) Glycosylinositolphosphate soluble ariant surface glycoprotein inhibitsIFN-gamma-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. J. Immunol., 171, 1466-1472.
73. Korf, J.E.; Pynaert, G.; Tournoy, K.; Boonefaes, T.; Van Oosterhout, A.; Ginneberge, D.; Haegeman, A.; Verschoor, J.A.; DeBaetselier, P. and Grooten, J. (2006) Macrophage reprogramming by mycolic acid promotes a tolerogenic response in experimentalasthma. Am. J. Respir. Crit. Care Med., 174, 152-160.
74. Guilliams, M.; Oldenhove, G.; Noel, W.; Herin, M.; Brys, L.; Loi, P.; Flamand, V.; Moser, M.; De Baetselier, P. and Beschin, A.(2007) African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated withsustained type 1 inflammation. J. Immunol., 179, 2748-2757.
75. Guilliams, M.; Bosschaerts, T.; Herin, M.; Hunig, T.; Loi, P.; Flamand, V.; De Baetselier, P. and Beschin, A. (2008) Experimen tal expansion of the regulatory T cell population increases resistance to African trypanosomiasis. J. Infect. Dis., 198, 781-791.
76. Namangala, B.; Noel, W.; De Baetselier, P.; Brys, L. and Beschin,A. (2001) Relative contribution of interferon-gamma and interleukin-10 to resistance to murine African trypanosomosis. J. Infect.Dis., 183, 1794-1800.
77. Guilliams, M.; Movahedi, K.; Bosschaerts, T.; VandenDriessche,T.; Chuah, M.K.; Herin, M.; Acosta-Sanchez, A.; Ma, L.; Moser, M.; Van Ginderachter, J.A.; Brys, L.; De Baetselier, P. and Beschin, A. (2009) IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection. J. Immunol., 182, 1107-1118.
78. Shi, M.; Wei, G.; Pan, W. and Tabel, H. (2006) Experimental African trypanosomiasis: a subset of pathogenic, IFN-gammaproducing,MHC class II-restricted CD4+ T cells mediates early mortality in highly susceptible mice. J. Immunol., 176, 1724-1732.
79. Stijlemans, B.; Guilliams, M.; Raes, G.; Beschin, A.; Magez, S. andDe Baetselier, P. (2007) African trypanosomosis: from immune escape and immunopathology to immune intervention. Vet. Parasitol., 148, 3-13.
80. Barkhuizen, M.; Magez, S.; Atkinson, R.A. and Brombacher, F. (2007) Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis. J. Infect. Dis., 196, 1253-1260.
81. Naessens, J.; Kitani, H.; Nakamura, Y.; Yagi, Y.; Sekikawa, K. and Iraqi, F. (2005) TNF-alpha mediates the development of anaemia ina murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection. Clin. Exp. Immunol., 139, 405-410.
82. Nok, A.J. and Balogun, E.O. (2003) A bloodstream Trypanosoma congolense sialidase could be involved in anemia during experimental trypanosomiasis. J. Biochem., 133, 725-730.
83. Esievo, K.A.; Saror, D.I.; Kolo, M.N. and Eduvie, L.O. (1986) Erythrocyte surface sialic acid in Ndama and Zebu cattle. J. Comp. Pathol., 96, 95-99.
84. Andrianarivo, A.G.; Muiya, P. and Logan-Henfrey, L.L. (1996) Trypanosoma congolense: high erythropoietic potential in infectedyearling cattle during the acute phase of the anemia. Exp. Parasitol., 82, 104-111.
85. Shi, M.; Wei, G.; Pan, W. and Tabel, H. (2005) Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense. Infect. Immun., 73, 8393-8396.
86. Anosa, V.O. and Kaneko, J.J. (1983) Pathogenesis of Trypanosoma brucei infection in deer mice (Peromyscus maniculatus): light and electron microscopic studies on erythrocyte pathologic changes andphagocytosis. Am. J. Vet. Res., 44, 645-651.
87. Wunder, C. and Potter, R.F. (2003) The heme oxygenase system:its role in liver inflammation. Curr. Drug Targets Cardiovasc. Haematol. Disord., 3, 199-208.
88. Weiss, G. and Goodnough, L.T. (2005) Anemia of chronic disease. N. Engl. J. Med., 352, 1011-1023.
89. Weiss, G. (2009) Iron metabolism in the anemia of chronic disease.Biochim. Biophys. Acta., 1790, 682-693.
90. Weiss, G. (2002) Pathogenesis and treatment of anaemia of chronicdisease. Blood Rev., 16, 87-96.
91. Noyes, H.A.; Alimohammadian, M.H.; Agaba, M.; Brass, A.;Fuchs, H.; Gailus-Durner, V.; Hulme, H.; Iraqi, F.; Kemp, S.; Rathkolb, B.; Wolf, E.; de Angelis, M.H.; Roshandel, D. and Naessens, J. (2009) Mechanisms controlling anaemia in Trypanosoma congolense infected mice. PLoS One, 4, e5170.
92. Igbokwe, I.O. (1989) Dyserythropoiesis in animal trypanosomosis. Rev. Elev. Med. Vet. Pays Trop., 42, 423-429.
93. Ogunsanmi, A.O.; Akpavie, S.O. and Anosa, V.O. (1994) Haematological changes in ewes experimentally infected with Trypanosoma brucei. Rev. Elev. Med. Vet. Pays. Trop., 47, 53-57.
94. Palis, J. (2004) Developmental biology: no red cell is an island. Nature, 432, 964-1945
95. Wang, C.Q.; Udupa, K.B. and Lipschitz, D.A. (1996) Evidence suggesting a stimulatory role for interleukin-10 in erythropoiesis in vitro. J. Cell Physiol., 166, 305-310.
96. Ojok, L.; Kaeufer-Weiss, I. and Weiss, E. (2001) Bone marrow response to acute and chronic Trypanosoma congolense infection in multimammate rats (Mastomys coucha). J. Comp. Pathol., 124, 149-158.
97. Merschjohann, K. and Steverding, D. (2006) In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators. Kinetoplastid Biol. Dis., 5, 3.
98. Steverding, D. (1998) Bloodstream forms of Trypanosoma brucei require only small amounts of iron for growth. Parasitol. Res., 84, 59-62.
99. Paul, K.S.; Jiang, D.; Morita, Y.S. and Englund, P.T. (2001) Fatty acid synthesis in African trypanosomes: a solution to the myristate mystery. Trends Parasitol., 17, 381-387.
100. Ferguson, M.A. (1999) The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J. Cell Sci., 112, 2799-2809.
101. Morita, Y.S.; Paul, K.S. and Englund, P.T. (2000) Specialized fatty acid synthesis in African trypanosomes: myristate for GPI anchors.Science, 288, 140-143.
102. Morita, Y.S. and Englund, P.T. (2001) Fatty acid remodeling of glycosyl phosphatidylinositol anchors in Trypanosoma brucei:incorporation of fatty acids other than myristate. Mol. Biochem. Parasitol., 115, 157-164.
103. Ganz, T. and Nemeth, E. (2009) Iron sequestration and anemia of inflammation. Semin. Hematol., 46, 387-393.
104. Munoz, M.; Villar, I. and Garcia-Erce, J.A. (2009) An update on iron physiology. World J. Gastroenterol., 15, 4617-4626.
105. Lopez-Bojorquez, L.N.; Dehesa, A.Z. and Reyes-Teran, G. (2004) Molecular mechanisms involved in the pathogenesis of septic shock. Arch. Med. Res., 35, 465-479.
106. Hamid, Q.; Tulic, M.K.; Liu, M.C. and Moqbel, R. (2003) Inflammatory cells in asthma: mechanisms and implications for therapy. J. Allergy Clin. Immunol., 111, S5-12; discussion S12-S17.
107. Malaguarnera, L. and Musumeci, S. (2002) The immune response to Plasmodium falciparum malaria. Lancet Infect. Dis., 2, 472-478.
108. Szabo, G.; Romics, L. Jr. and Frendl, G. (2002) Liver in sepsis andsystemic inflammatory response syndrome. Clin. Liver Dis., 6, 1045-1066.
109. Wang, J.; Van Praagh, A.; Hamilton, E.; Wang, Q.; Zou, B.; Muranjan, M.; Murphy, N.B. and Black, S.J. (2002) Serum xanthine oxidase: origin, regulation, and contribution to control oftrypanosome parasitemia. Antioxid. Redox Signal, 4, 161-178.
110. Black, S.J.; Sicard, E.L.; Murphy, N. and Nolan, D. (2001) In nateand acquired control of trypanosome parasitaemia in Cape buffalo. Int. J. Parasitol., 31, 562-565.
111. Chattopadhyay, A.; Jones, N.G.; Nietlispach, D.; Nielsen, P.R.; Voorheis, H.P.; Mott, H.R. and Carrington, M. (2005) Structure of the C-terminal Domain from Trypanosoma brucei Variant Surface Glycoprotein MITat1.2. J. Biol. Chem., 280, 7228-7235.
112. Marcello, L.; Menon, S.; Ward, P.; Wilkes, J.M.; Jones, N.G.; Carrington, M. and Barry, J.D. (2007) VSGdb: a database for trypanosome variant surface glycoproteins, a large and diverse family of coiled coil proteins. BMC Bioinformatics, 8, 143.